See related commentary by Christaki and Patrozou, <http://ccforum.com/content/14/2/132> and related research by Hein *et al.*, <http://ccforum.com/content/14/1/R19>

We would like to revisit the commentary by Christaki and Patrozou \[[@B1]\] on regulatory T cells (Tregs) as significant modulators of various immune responses after severe injury. Indeed, we would like to add some very recent references that strongly reinforce their results.

Strong evidence indicates that, in septic conditions, increases in Tregs have deleterious consequences. In septic shock patients, augmented levels of Tregs significantly and inversely correlated with decreased lymphocyte proliferation \[[@B2]\]. This phenomenon, recapitulated after cecal ligation and puncture (CLP) in mice, was totally abrogated by using *Foxp3*small interfering RNA (Foxp3 is a specific Treg transcription factor). In a similar model \[[@B3]\], after mild CLP, mice presented with immunosuppression that dampened defenses against secondary infectious challenge (*Legionella pneumophilia*inoculation 15 days after CLP). The restoration of efficient responses against infection was achieved thanks to anti-glucocorticoid-induced TNF receptor antibodies, known to abrogate Treg-mediated suppression. Lastly, a recent paper published in *Blood*\[[@B4]\] reported that sepsis-induced immunosuppression resulted in a reduced immune tolerance that facilitated the rapid growth of solid tumors. *Foxp3*+ Tregs were responsible for this effect. Although tumors were subcutaneously implanted (which is not relevant to septic patients), this indicates the occurrence of a major immunosuppressive state induced by sepsis and driven by Tregs in this model.

Collectively, and beyond Tregs (unfortunately not the sole bad guys in the game), these data highlight the profound impact of sepsis/injury on immune functions. This should stimulate basic research and development of innovative therapies for rebalancing immune homeostasis in severe critical illness.
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